At Dhee Lifesciences, we transform complex, unstable, and clinically constrained molecules into development-ready therapeutic assets.
By integrating predictive intelligence with advanced formulation engineering, we enable a structured, reliable pathway from molecule to clinic.
The Dhee Principle
Intellect as a development principle
The name Dhee (ΰ€§ΰ₯) originates from the Sanskrit concept of intellect, insight, and informed decision-making.
At Dhee Lifesciences, this principle defines how we approach drug development.
We do not rely on iterative trial-and-error.
We apply structured scientific reasoning to guide decisions across formulation, delivery, and clinical translation.
β Our Philosophy
We do not accept limitations as endpoints
Pharmacokinetic constraintsβpoor solubility, low bioavailability, instability, and systemic toxicityβare often treated as unavoidable.
We treat them as engineering problems .
By combining predictive modelling with delivery system design, we create solutions that enable molecules to perform in real biological systems.
This approach extends beyond formulation. We collaborate on molecular design, biological questions, and enabling technologiesβbringing together multidisciplinary insight to solve complex development challenges.
HOW WE OPERATE
A translational development engine
We do not approach development as isolated capabilities. We operate as an integrated system combining intelligence, engineering, and execution
Delivery & Formulation Engineering
We design systems that determine how molecules:
- Survive in formulation
- Move through biological systems
- Activate at the right site
- Deliver predictable exposure
SynapTxβ’ Intelligence Layer
Our proprietary platform integrates scientific literature, clinical data, and development knowledge to guide decisions before laboratory execution begins.
It enables:
- Predictive pharmacokinetic modelling
- Evidence synthesis across studies and patents
- Early identification of development risks
- Strategy design for formulation and translation
CMC & Manufacturing Integration
We align development with real-world requirements from the outset:
- Scalable manufacturing pathways
- Regulatory-aligned CMC strategies
- Seamless transition from lab to clinic
WHAT WE DO
Engineering molecules for clinical success
We collaborate across molecules, biological systems, and enabling technologies to solve complex development challenges.
Our work spans:
- Molecular optimisation and re-engineering
- Biological and pharmacokinetic problem-solving
- Development of advanced delivery systems
From early-stage concepts to clinical-ready programmes, we design integrated pathways that address unmet medical needs.
HOW WE CREATE VALUE
From uncertainty to predictability
We systematically address the core failure points in drug development:
Instability
engineered protection and control
Poor solubility
advanced delivery architectures
Systemic toxicity
targeted activation strategies
Clinical variability
predictable pharmacokinetic design
Our focus is not incremental optimisationβit is fundamental improvement in translational success
A platform-driven approach
A repeatable system across therapeutic domains
Our programmes span diverse therapeutic areasβbut follow a single engineering framework.
We focus on:
- Clinically validated molecules limited by delivery
- High-value biological mechanisms constrained by translation
- Opportunities where formulation and CMC determine success
HOW WE WORK WITH PARTNERS
Collaborative, science-first engagement
We do not operate as service providers.
We collaborate as technical partners in building development programmes.
Co-Development
Joint design and execution of therapeutic programmes
Molecule Rescue
Re-engineering stalled or failed assets through delivery innovation
Platform Integration
Applying SynapTx and formulation expertise to partner pipelines
Technology Co-Creation
Developing new delivery systems and translational strategies together
Where we engage
We engage across molecules, biological systems, and enabling technologies β bringing together diverse scientific perspectives into a single, execution-ready pathway.
We collaborate across:
- Complex small molecules and cytotoxic agents
- Immune, oncological, and endocrine systems
- Advanced delivery and controlled-release architectures
Our work sits at the intersection of: science, engineering, and clinical translation
TRUST & CONFIDENTIALITY
WHO WE WORK WITH
Designed for serious development programmes
We work with:
- Pharmaceutical companies with active pipelines
- Biotech innovators addressing translational challenges
- Research organisations exploring novel therapeutic strategies
Bring your most challenging molecule
Whether you are advancing a new therapeutic, addressing a delivery challenge, or reviving a stalled programme, we provide the scientific and technical architecture to move forward with confidence.
Confidential engagement. IP-protected discussions. Scientific-first approach.